Announced Tue, 26 May · 15:34 IST

Schedule of Investor Meet

Board & Shareholder Meetings View source PDF

GLAND · price

Loading chart…

▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.

Price reaction · full curve 14 horizons · vs prior close

-2.5%1-day move

₹2302.40

prior close

₹2324.10

base price

After-mkt

timing

5m10m15m30m1D2D3D4D5D7D15D1M2M3M

+0.8+0.5+0.3+0.2-2.5-0.4-1.5-3.1-3.4-2.4-4.4+3.0+5.5—

Up moveDown movePending

AI summary

Gland Pharma has disclosed its upcoming investor meeting schedule to the stock exchanges. Two meetings are planned: a one-on-one meeting with Carnelian Asset Management on June 1, 2026, and participation in the ICICI Securities India Investor Conference 2026 on June 8, 2026, which includes both one-on-one and group meetings. The company notes that schedules are subject to change due to exigencies. This filing is made under SEBI LODR Regulation 30, which requires listed companies to disclose investor interaction schedules.

Likely market impact

This is a routine regulatory compliance filing and does not contain any material corporate news or financial updates. The scheduled meetings may provide institutional investors with business updates, but the filing itself offers no new information that would directly impact the stock.